DocuSign, Inc. (NASDAQ:DOCU) Insider Sells $1,306,582.14 in Stock

DocuSign, Inc. (NASDAQ:DOCU - Get Free Report) insider Robert Chatwani sold 15,706 shares of DocuSign stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $83.19, for a total value of $1,306,582.14. Following the completion of the sale, the insider now directly owns 76,842 shares in the company, valued at approximately $6,392,485.98. The trade was a 16.97 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

DocuSign Trading Down 0.6 %

NASDAQ DOCU opened at $85.11 on Friday. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86. The company's 50-day moving average price is $87.58 and its 200-day moving average price is $79.95. The stock has a market cap of $17.19 billion, a PE ratio of 17.55, a PEG ratio of 6.94 and a beta of 1.02.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. The business had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company's quarterly revenue was up 9.0% compared to the same quarter last year. During the same period last year, the company posted $0.76 earnings per share. As a group, sell-side analysts forecast that DocuSign, Inc. will post 1.17 earnings per share for the current year.

Wall Street Analysts Forecast Growth




Several equities research analysts recently weighed in on DOCU shares. JPMorgan Chase & Co. upgraded shares of DocuSign from an "underweight" rating to a "neutral" rating and boosted their price target for the stock from $70.00 to $75.00 in a research report on Monday, March 10th. Piper Sandler increased their price target on shares of DocuSign from $60.00 to $90.00 and gave the company a "neutral" rating in a report on Friday, December 6th. Jefferies Financial Group boosted their price objective on DocuSign from $80.00 to $95.00 and gave the stock a "buy" rating in a research note on Tuesday, December 3rd. Morgan Stanley lifted their target price on DocuSign from $62.00 to $97.00 and gave the stock an "equal weight" rating in a report on Friday, December 6th. Finally, Bank of America decreased their price target on DocuSign from $112.00 to $98.00 and set a "neutral" rating on the stock in a report on Friday, March 14th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, DocuSign presently has a consensus rating of "Hold" and a consensus price target of $95.00.

Get Our Latest Stock Analysis on DOCU

Institutional Investors Weigh In On DocuSign

Hedge funds have recently made changes to their positions in the company. Itau Unibanco Holding S.A. bought a new stake in shares of DocuSign in the third quarter valued at about $28,000. Kestra Investment Management LLC bought a new stake in shares of DocuSign in the 4th quarter valued at about $30,000. Brooklyn Investment Group purchased a new stake in shares of DocuSign in the 3rd quarter worth approximately $33,000. Modus Advisors LLC bought a new position in shares of DocuSign during the fourth quarter valued at approximately $36,000. Finally, First Horizon Advisors Inc. increased its holdings in DocuSign by 102.6% during the fourth quarter. First Horizon Advisors Inc. now owns 397 shares of the company's stock valued at $36,000 after buying an additional 201 shares during the period. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

About DocuSign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Insider Buying and Selling by Quarter for DocuSign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.

Insider Buying or Selling at DocuSign?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for DocuSign and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles